Search





Search





Markets
/
Stocks
/
vtgn
/

Vistagen Therapeutics Inc

VTGN

Add to Watchlist

0.241USD

0.0000.00%

Close 07-31 16:00（ET）Quotes delayed by 15 min

9.55MMarket Cap

LossP/E TTM

Vistagen Therapeutics Inc

0.241

0.0000.00%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

3.00

Change

The current institutional shareholding score of Vistagen Therapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 37.96%, representing a quarter-over-quarter decrease of 34.37%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.74% of shares outstanding, with 0.65% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

OrbiMed Advisors, LLC

3.06M

TCG Crossover Management, LLC

2.68M

Adar1 Capital Management LLC

623.58K

+451.53%

Ikarian Capital LLC

519.08K

-16.40%

BlackRock Institutional Trust Company, N.A.

416.83K

-0.24%

Geode Capital Management, L.L.C.

352.84K

+18.29%

Luminus Management, L.L.C.

350.00K

Susquehanna International Group, LLP

334.79K

+291.13%

Two Sigma Investments, LP

333.30K

-25.34%